Overview / Abstract: |
Expert faculty for this 30-minute webinar will include a gynecologic oncologist and a nurse. This webinar will provide an overview of the latest data in PARP inhibitor therapy for the treatment of ovarian cancer in patients with different biomarker profiles and at different stages of the disease. Recent clinical data and rationale for PARP inhibitor use in the first-line maintenance setting will be discussed. Faculty will share unique toxicity profiles among the different PARP inhibitors and best practices in monitoring, preventing, and treating adverse events that may arise with therapy. |
Expiration |
Apr 30, 2023 |
Discipline(s) |
Physician CME |
Format |
Online, Webinar / Webcast / Video |
Credits / Hours |
0.5 |
Accreditation |
ACCME |
Is This Activity Certified for "Live" Credit? |
YES |
Presenters / Authors / Faculty |
Beth Y. Karlan, MD Jennifer Filipi, MSN, NP |
Activity Specialities / Related Topics |
OB/GYN / Women's Health, Oncology / Cancer / Radiation Therapy |
Sponsors / Supporters / Grant Providers |
Supported through an independent educational grant from GlaxoSmithKline. |
Keywords / Search Terms |
CE Concepts Oncology CME,PARP Inhibitors,OBGYN CME,Ovarian Cancer,PARP Inhibitors,Free CME,Cancer CME,Ovarian CME Free CE CME Live CE CME |